In adenocarcinoma patients, the association between the PDCD1 -rs2227982 polymorphism and platinum-based chemotherapy resistance did not reach statistical significance under the genotypic, recessive, or additive models.
← all excerpts
Immune Checkpoint-Related Gene Polymorphisms and High Serum Concentration of PD-L1 and CTLA4 Contribute to the Resistance to Platinum-Based Chemotherapy in Cervical Cancer.
1
—
—